Girard Partners LTD. lowered its position in shares of Colgate-Palmolive Company (NYSE:CL) by 37.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 28,533 shares of the company’s stock after selling 17,351 shares during the period. Girard Partners LTD.’s holdings in Colgate-Palmolive Company were worth $2,088,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Quest Investment Management Inc. OR increased its stake in Colgate-Palmolive Company by 10.5% in the fourth quarter. Quest Investment Management Inc. OR now owns 76,609 shares of the company’s stock valued at $5,013,000 after buying an additional 7,292 shares in the last quarter. Chickasaw Capital Management LLC increased its stake in Colgate-Palmolive Company by 218.3% in the first quarter. Chickasaw Capital Management LLC now owns 16,920 shares of the company’s stock valued at $1,238,000 after buying an additional 11,605 shares in the last quarter. Meritage Portfolio Management increased its stake in Colgate-Palmolive Company by 0.3% in the first quarter. Meritage Portfolio Management now owns 95,879 shares of the company’s stock valued at $7,017,000 after buying an additional 255 shares in the last quarter. Eastern Bank increased its stake in Colgate-Palmolive Company by 0.8% in the first quarter. Eastern Bank now owns 10,939 shares of the company’s stock valued at $801,000 after buying an additional 89 shares in the last quarter. Finally, ProShare Advisors LLC increased its stake in Colgate-Palmolive Company by 9.9% in the first quarter. ProShare Advisors LLC now owns 879,652 shares of the company’s stock valued at $64,382,000 after buying an additional 79,323 shares in the last quarter. 74.13% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Colgate-Palmolive Company (NYSE CL) opened at 75.89 on Tuesday. The company’s 50 day moving average is $74.49 and its 200 day moving average is $71.10. Colgate-Palmolive Company has a 12-month low of $63.43 and a 12-month high of $77.27. The company has a market capitalization of $67.03 billion, a P/E ratio of 27.39 and a beta of 0.82.

Colgate-Palmolive Company (NYSE:CL) last released its quarterly earnings results on Friday, April 28th. The company reported $0.67 EPS for the quarter, beating analysts’ consensus estimates of $0.66 by $0.01. The business had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.80 billion. Colgate-Palmolive Company had a return on equity of 3,725.55% and a net margin of 16.31%. Colgate-Palmolive Company’s quarterly revenue was up .0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.63 EPS. Analysts expect that Colgate-Palmolive Company will post $2.92 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Tuesday, July 18th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, July 14th. This represents a $1.60 dividend on an annualized basis and a yield of 2.11%. Colgate-Palmolive Company’s dividend payout ratio (DPR) is presently 57.76%.

COPYRIGHT VIOLATION WARNING: This piece was reported by Daily Political and is the property of of Daily Political. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.dailypolitical.com/2017/06/27/girard-partners-ltd-sells-17351-shares-of-colgate-palmolive-company-cl.html.

Several research firms have commented on CL. Bank of America Corporation boosted their target price on shares of Colgate-Palmolive Company from $78.00 to $80.00 and gave the stock a “buy” rating in a research report on Wednesday, May 31st. BidaskClub downgraded shares of Colgate-Palmolive Company from a “hold” rating to a “sell” rating in a research report on Saturday. Vetr downgraded shares of Colgate-Palmolive Company from a “buy” rating to a “hold” rating and set a $76.67 target price for the company. in a research report on Wednesday, May 17th. Royal Bank Of Canada reissued a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive Company in a research report on Thursday, May 25th. Finally, Jefferies Group LLC began coverage on shares of Colgate-Palmolive Company in a research report on Tuesday, April 18th. They issued a “hold” rating and a $78.00 target price for the company. One investment analyst has rated the stock with a sell rating, fourteen have given a hold rating and two have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $75.41.

In other Colgate-Palmolive Company news, insider Patricia Verduin sold 3,833 shares of the company’s stock in a transaction on Thursday, June 15th. The stock was sold at an average price of $75.67, for a total value of $290,043.11. Following the completion of the transaction, the insider now owns 53,022 shares in the company, valued at approximately $4,012,174.74. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard J. Kogan sold 8,000 shares of the company’s stock in a transaction on Monday, May 8th. The shares were sold at an average price of $71.92, for a total value of $575,360.00. Following the completion of the transaction, the director now owns 73,065 shares of the company’s stock, valued at approximately $5,254,834.80. The disclosure for this sale can be found here. Insiders sold a total of 43,666 shares of company stock valued at $3,184,972 in the last 90 days. Corporate insiders own 1.02% of the company’s stock.

Colgate-Palmolive Company Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive Company (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.